Sign Up to like & get
recommendations!
1
Published in 2019 at "Cell metabolism"
DOI: 10.1016/j.cmet.2019.03.010
Abstract: Phosphatidylinositol-3-kinase (PI3K) activity is aberrant in tumors, and PI3K inhibitors are investigated as cancer therapeutics. PI3K signaling mediates insulin action in metabolism, but the role of PI3K isoforms in insulin signaling remains unresolved. Defining the…
read more here.
Keywords:
insulin;
pi3k;
pi3k pi3k;
insulin driven ... See more keywords